TY - JOUR
T1 - Estimating time and transportation costs associated with lung cancer screening and diagnostic lung procedures in Taiwan
T2 - A cross-sectional survey in a medical centre
AU - Wu, Chi Hao
AU - Ku, Li Jung Elizabeth
AU - Lin, Chien Yu
AU - Chung, Ta Jung
AU - Liu, Hui Ju
AU - Chao, Ting Hsing
AU - Yang, Szu Chun
N1 - Funding Information:
Supported by the Ministry of Science and Technology (110–2314-B-006–100-MY2) and National Cheng Kung University Hospital (NCKUH-11203001).
Publisher Copyright:
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2023/3/10
Y1 - 2023/3/10
N2 - Objectives Earlier research has evaluated the non-medical costs after lung cancer diagnosis. This study estimated the time costs and transportation costs associated with low-dose CT (LDCT) screening and diagnostic lung procedures in Taiwan. Design Cross-sectional study. Setting A tertiary referral medical centre. Participants and interventions The study participants were individuals aged 50-80 years who underwent LDCT screening or diagnostic lung procedures between 2021 and 2022. Participants completed a questionnaire including items on time spent on receiving care, time spent on travel and its cost and time taken off from work by the participant and any accompanying caregiver. Outcome measures Time costs were valued using the age- and sex-specific average daily wage for employed participants/caregivers. Costs of informal healthcare sector consisted of time cost of the participant, transportation cost and time cost of the caregiver. Results A total of 209 participants who underwent LDCT screening (n=84) or non-surgical (n=12) or surgical (n=113) diagnostic lung procedures for the first time were enrolled. Considering the purchasing power parity, the average costs of informal healthcare sector were US$126.4 (95% CI 101.6 to 151.2), US$290.7 (95% CI 106.9 to 474.5) and US$749.8 (95% CI 567.3 to 932.4), respectively, for LDCT screening, non-surgical procedures and surgical procedures. Conclusions This study estimated time and transportation costs associated with LDCT screening and diagnostic lung procedures, which could be used for future analysis of cost-effectiveness of lung cancer screening in Taiwan.
AB - Objectives Earlier research has evaluated the non-medical costs after lung cancer diagnosis. This study estimated the time costs and transportation costs associated with low-dose CT (LDCT) screening and diagnostic lung procedures in Taiwan. Design Cross-sectional study. Setting A tertiary referral medical centre. Participants and interventions The study participants were individuals aged 50-80 years who underwent LDCT screening or diagnostic lung procedures between 2021 and 2022. Participants completed a questionnaire including items on time spent on receiving care, time spent on travel and its cost and time taken off from work by the participant and any accompanying caregiver. Outcome measures Time costs were valued using the age- and sex-specific average daily wage for employed participants/caregivers. Costs of informal healthcare sector consisted of time cost of the participant, transportation cost and time cost of the caregiver. Results A total of 209 participants who underwent LDCT screening (n=84) or non-surgical (n=12) or surgical (n=113) diagnostic lung procedures for the first time were enrolled. Considering the purchasing power parity, the average costs of informal healthcare sector were US$126.4 (95% CI 101.6 to 151.2), US$290.7 (95% CI 106.9 to 474.5) and US$749.8 (95% CI 567.3 to 932.4), respectively, for LDCT screening, non-surgical procedures and surgical procedures. Conclusions This study estimated time and transportation costs associated with LDCT screening and diagnostic lung procedures, which could be used for future analysis of cost-effectiveness of lung cancer screening in Taiwan.
UR - http://www.scopus.com/inward/record.url?scp=85150001599&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85150001599&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2022-070647
DO - 10.1136/bmjopen-2022-070647
M3 - Article
C2 - 36898750
AN - SCOPUS:85150001599
SN - 2044-6055
VL - 13
JO - BMJ open
JF - BMJ open
IS - 3
M1 - e070647
ER -